Top Tech Companies in Boston, MA (4,760)

Strong Revenue Growth: Reporting indicates revenue increased in successive years, with UK results showing clear year-over-year gains and the parent highlighting category increases linked to the business. This pattern points to solid top-line momentum across core operations.

Profitability: Operating and post-tax profit improved materially, at times outpacing revenue growth. Such margin expansion suggests enhanced earning efficiency and disciplined execution.

Market Expansion: Customer reach advanced to a major UK milestone while U.S. distribution broadened through accelerated agent activity and additional channels. New insurer partnerships and digital launches further extend access to buyers.

Strong Revenue Growth: Recent financials show accelerating top-line expansion, with quarterly revenue surpassing the billion-dollar mark and full-year results climbing meaningfully. Momentum continued into 2026, reflecting broad demand across observability, security, and AI-related offerings.

Healthy Cash Flow: Operations are generating substantial operating and free cash flow alongside growth. This pattern persisted through mid-2026, indicating efficient scaling.

Strong Market Position & Advantage: Industry evaluations repeatedly place the company as a Leader in observability and digital experience monitoring, including top positioning for execution. Recognition such as Customers’ Choice and multi-product leadership suggests deep adoption and competitive strength.

Strong Revenue Growth: Revenue is increasing at a double‑digit pace, with Q2 2026 revenue of about $1.91B up year over year. Full-year 2025 revenue also rose meaningfully to roughly $6.15B from $4.96B the prior year, indicating momentum across periods.

Profitability: Profitability is improving, as Q2 2026 net income increased to about $154M and operating income to roughly $152M from the prior year’s quarter. Recurring gross profit from subscription and fintech reached approximately $585M, showing stronger unit economics alongside scale.

Market Expansion: Customer reach is widening, with roughly 9,500 net locations added in Q2 2026 and total locations around 180,000, both higher than a year earlier. The company is also extending into retail, enterprise, international markets, and AI-enabled products such as Toast IQ.

Investor Backing & Capital Strength: Evidence indicates a $50 million Series D in April 2026 led by Boehringer Ingelheim, following a Series C in March 2025. This ongoing capital access, including dedicated commercialization funding, signals strong financial support for the next phase of growth.

Strategic Partnerships: Evidence indicates deep relationships with Boehringer Ingelheim and Otsuka, alongside new collaborations such as Ultrahuman for migraine-related technology. These alliances are described as enabling development, regulatory progress, and commercialization pathways across multiple programs.

Product Line Growth: Evidence indicates multiple FDA milestones—Rejoyn for major depressive disorder symptoms (2024), CT-132 for episodic migraine prevention (2025), and Motivista/CT-155 for negative symptoms of schizophrenia (2026)—plus expansion into obesity and cardiometabolic disease via acquired assets. These developments broaden the portfolio across therapeutic areas and advance late-stage candidates toward market.

Strong Revenue Growth: Revenue has scaled to over $1.2B with continued double-digit quarterly increases and an outlook nearing $1.5B, indicating sustained momentum. Guidance increases reinforce the trajectory of ongoing top-line expansion.

Market Expansion: International revenue is growing faster than the overall business and now represents a significant share of total revenue, with customers across more than 100 countries. The customer base surpassing 205,000 underscores broader geographic reach and upmarket penetration.

Customer Loyalty & Retention: Net revenue retention remains above 100%, suggesting existing customers are expanding spend through cross-selling and wider platform adoption. Larger-account cohorts are growing rapidly, including rising counts of $50K+ and $1M+ ARR customers.

Market Expansion: Company disclosures indicate a larger commercial footprint, with the enterprise customer count rising from 600+ in 2022 to 900+ by 2026 alongside a broadened partner network. Momentum in the United States is highlighted as particularly strong, with leadership hires pointing to continued geographic focus.

Product Line Growth: Recent moves such as the PricingHUB acquisition and the introduction of agentic AI capabilities point to an expanded platform spanning product information, pricing, and AI-enabled commerce. Product activation reach has also widened to hundreds of destinations, signaling broader use cases and distribution.

Strong Market Position & Advantage: Industry recognition includes being named a Leader in Gartner’s 2026 Magic Quadrant for PIM, supported by additional analyst validations across recent years. Such positioning suggests competitive strength in a category with rising demand for structured product data.

Strong Revenue Growth: Recent results show revenue up 27.2% year over year in Q2 2026, with full-year 2025 revenue rising 26.6% to $623 million. Management also raised its 2026 growth outlook, reinforcing the trajectory.

Market Expansion: Client additions of 200+ across 45 countries in both Q1 and Q2 2026 and growth beyond education into travel, healthcare, and B2B indicate a broadening footprint. Education revenue outside core markets growing 30%+ further supports geographic expansion.

Profitability: Adjusted EBITDA increased 44.5% in Q2 2026 with margin expansion, and full-year 2025 reported positive net income. These trends suggest improving earnings power alongside scale.

Strong Revenue Growth: Annual revenue rose from $3.67B in 2023 to $6.05B in 2025, and management guides to $6.5–$6.9B for 2026. This multi-year trajectory signals substantial top-line expansion despite quarterly volatility.

Market Expansion: The sportsbook operates in 30 states, Washington, D.C., Puerto Rico, and parts of Canada. Broader geographic access supports continued user and wagering growth.

Diversified Revenue Streams: Sportsbook, iGaming, and the newer Predictions offering provide multiple growth avenues. iGaming revenue grew 7.5% year over year in Q2 2026, while Predictions launched in December 2025 as another channel.

Investor Backing & Capital Strength: Capital raising includes a $372 million Series D in 2024 with participation from Sanofi, bringing total funding above $600 million. The stated use of proceeds was to expand the drug pipeline and AI platform, indicating a strong financial base for growth.

Product Line Growth: The portfolio has expanded through multiple in-licensing deals in 2025–2026 and now spans preclinical, Phase 1, and Phase 2 programs. Tangible execution includes dosing the first participant in the BLKR201 Phase 1 trial in June 2026, only months after licensing the asset.

Strategic Partnerships: High-profile collaborations include work with Sanofi and OpenAI to build AI tools for drug development, alongside a Sanofi licensing agreement for gusacitinib with significant potential milestone value. These relationships reinforce external validation and create pathways to scale development.

Strong Revenue Growth: Company disclosures indicate double-digit revenue growth in 2024 and continued momentum via 30% year-over-year new-business growth in 2025. Reported 107% net retention further supports expansion of recurring revenue within the existing base.

Market Expansion: Reported 2.5× growth in cloud, SASE, and microsegmentation in 2025 points to traction beyond traditional network-policy management. Ongoing AI-driven launches and partnerships in 2025–2026 reinforce expansion into adjacent markets.

Customer Loyalty & Retention: A 2025 customer net retention rate of 107% suggests existing accounts expanded their spend after churn and contractions were accounted for. An NPS of 71, up sharply year over year, indicates rising advocacy alongside retention.

Market Expansion: Acquisitions of Lab4U in 2026 and earlier formation/acquisition of Education at Work, alongside a grant network spanning more than 100 organizations across 49 states and Puerto Rico, indicate a widening national footprint. These moves show ongoing investment in expanding access and capabilities beyond the rebrand.

Product Line Growth: Adding Lab4U expands STEM learning and career exploration offerings, while Education at Work extends into paid, flexible work-based learning. Together these initiatives broaden Britebound’s portfolio beyond digital exploration into hands-on and employer-linked programs.

Investor Backing & Capital Strength: Audited statements show total assets rising year over year and net investment returns increasing materially, supplemented by previously disclosed social-bond funding. This capital base appears to underwrite program growth, grants, and acquisitions even amid mixed operating results.

Strong Revenue Growth: Revenue is rising steadily, including 11% year-over-year growth to $192.8 million in Q2 2026 and 7% growth for full-year 2025. The step-up from 6% growth in Q1 2026 to 11% in Q2 indicates accelerating momentum.

Profitability: Adjusted EBITDA increased 30% year over year in Q2 2026 as margin expanded from 34% to 37%, signaling operating leverage. Net income also improved to $19.4 million from $11.1 million year over year in that quarter.

Healthy Cash Flow: Guidance points to free-cash-flow growth in the high-40% range for 2026 alongside adjusted EBITDA growth of more than 20%. Operating cash flow reached $57.4 million in Q2 2026.

Strong Revenue Growth: Square’s segment revenue increased 10% in 2025 and rose 16% year over year in Q2 2026, pointing to renewed topline momentum. These gains accompany rising seller activity and broader ecosystem adoption.

Profitability: Gross profit reached about $1.16 billion in Q2 2026, up 13% year over year, after a 9% increase for full-year 2025. The trend indicates improving economic contribution from processing, software, and financial services.

Market Expansion: International GPV grew 28% year over year in Q2 2026 while U.S. GPV rose 10%, alongside traction with larger merchants and vertical solutions such as restaurants and banking. These patterns suggest widening geographic and segment reach.

Strong Revenue Growth: Revenue is rising at a reported 48% in 2025, with annualized revenue surpassing $300 million and nearing $400 million by August 2026. These figures indicate rapid scaling at a substantial revenue base.

Product Line Growth: The platform has expanded beyond business travel into expenses, invoices, corporate spending, and events, reinforced by the Yokoy acquisition. This broader offering increases opportunities to sell additional services to existing customers.

Market Expansion: Geographic reach is widening, including the U.S. launch of Perk Spend and growth initiatives that made the U.S. account for about 30% of global new business. Additional international moves, such as new offices, support continued growth outside the core markets.

Profitability: Operating and net income remained positive even as revenue softened in recent quarters. This indicates an earnings base that is holding up during a period of slower demand.

Healthy Cash Flow: Free cash flow stayed positive with meaningful generation quarter to quarter, and guidance points to continued cash production. Liquidity is reinforced by a sizable balance of cash, cash equivalents, and government securities.

Future-Ready Strategy: Management is concentrating investment on the Command Platform, detection and response, exposure management, and AI-enabled security operations. This refocus aims to position the portfolio for a return to growth once the transition progresses.

Strong Revenue Growth: Reported bookings and subscription revenue more than doubled in 2025, indicating accelerating commercial scale. Membership expanded into the millions by mid-2026, reinforcing top-line momentum.

Market Expansion: International membership surged and the company broadened distribution into retail, wholesale, and enterprise channels, extending growth beyond direct-to-consumer. Positioning widened from elite athletes to everyday health, sleep, and longevity use cases.

Investor Backing & Capital Strength: A substantial Series G at a markedly higher valuation brought significant capital from institutional and strategic investors. The raise supported planned headcount expansion and continued product development.

Strong Revenue Growth: Revenue is portrayed as having risen significantly over recent years, reflecting strong commercial momentum. Repeated acknowledgments of rapid multi-year growth support the view that top-line expansion has been substantial.

Strong Market Position & Advantage: Adoption reportedly spans more than 130 property-and-casualty carriers, including many top-tier insurers, indicating meaningful penetration in its niche. Named carrier relationships and integration within established insurance ecosystems reinforce credibility.

Product Line Growth: The company has expanded beyond claims communication into policyholder service, AI assistants, workflow automation, and a network connecting carriers with service providers. These moves suggest a broader addressable market and deeper value within existing accounts.

Strong Revenue Growth: Revenue is advancing at double-digit rates across multiple periods, with FY2026 revenue rising 19% to about $2.02B and fiscal Q1 FY2027 revenue up 16% to $555M. ARR also increased 17% in the latest quarter, reinforcing breadth of growth in a subscription model.

Healthy Cash Flow: Cash generation is robust, including approximately $529M in free cash flow for FY2026 and operating cash flow of roughly $306M in Q1 FY2027. These indicators suggest expansion is supported by solid liquidity rather than heavy cash burn.

Product Line Growth: Log management is scaling rapidly, with annualized consumption reaching about $200M in Q1 FY2027 and growing at more than 100% year over year. Investment in AI-powered operations and platform capabilities is extending the growth runway.

Product Line Growth: Product expansion into industrial robotics with kilo alongside ongoing consumer variants (e.g., Star Wars-inspired gitamini) and feature updates points to a broader offering. This widens the use cases from personal cargo robots to workplace and industrial material handling.

Market Expansion: A visible pivot toward B2B use cases, including planned factory deployments and stated fleet rollouts with several Fortune Global 500 companies, indicates broader commercial reach. The Disney collaboration adds an additional retail channel and audience for consumer products.

Innovation-Driven Growth: Continued technology investment—such as hybrid-navigation AI, Forward Following, and Trips—shows an active R&D agenda. A large human-motion dataset and iterative capability releases suggest efforts to improve commercial usefulness in dynamic environments.

Investor Backing & Capital Strength: A $325 million Series C at a reported $3 billion valuation, led by Spark Capital with participation from firms such as Andreessen Horowitz, signals strong capital access and confidence in future scale. The company describes using this capital to expand aviation, defense, energy, logistics, research, and engineering operations.

Market Expansion: Major awards like the FAA’s 12-year program (reported up to $875 million) and a five-year, $99 million U.S. Army contract, alongside airline customers and a National Grid collaboration, indicate expansion across government, commercial, and energy sectors. Partnerships such as Joby Aviation and new defense programs (e.g., DIU and the Open Mission Engine) further extend reach beyond the original aviation focus.

Strong Hiring & Retention: Dealroom reports 26.3% annual team growth with an estimated 173 employees and open positions, while another market source cites an increase from 163 to 228 in a quarter. Active recruiting across engineering, machine learning, cloud, mission operations, and growth roles points to organizational scaling.